A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the ...
Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...
Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
The capacity of an organism to regenerate depends on cell dedifferentiation followed by proliferation. Mammals, in general, have limited regenerative capacity. Now, a team of researchers at the Salk ...
Researchers highlighted how an arginine- and proline-restricted diet combined with eflornithine reprogrammed MYCN-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results